December 21, 2023
2 mins read

WHO Declares JN.1 as Standalone Covid Variant

Though JN.1 is now restricted to its circulation in the US, it is responsible for an estimated 1 in 5 new coronavirus infections, according to data from the Centers for Disease Control and Prevention…reports Asian Lite News

The World Health Organization (WHO) has declared the new Covid-19 variant — JN.1 — as a “standalone variant of interest”.

WHO’s decision was prompted by the variant’s ability to spread fast among the community. It said the decision was due to the strain’s ‘rapidly increasing spread’.

The WHO on Tuesday announced that it is classifying a new Covid-19 strain – JN.1 – as a standalone variant of interest “due to its rapidly increasing spread”, media reports said adding that the new variants’ characteristics and a growth advantage over other strains in circulation prompted the early warning, reports said.

Though WHO assessed the global public health risk of JN.1 as low, it warned that countries approaching winter should be aware that Covid-19 and other pathogens may exacerbate respiratory disease seasons.

“Despite this, with the onset of winter in the Northern Hemisphere, JN.1 could increase the burden of respiratory infections in many countries,” it said.

Though JN.1 is now restricted to its circulation in the US, it is responsible for an estimated 1 in 5 new coronavirus infections, according to data from the Centers for Disease Control and Prevention.

The agency expects that JN.1’s prevalence in the US will continue to increase in the winter months.

WHO considers BA.2.86 sub lineages to be variants of interest, but now JN.1 is listed as a variant of interest separate from its parent lineage, also known as pirola.

WHO defines a variant of interest as a strain with genetic mutations, according to US News & World Report.

Covid-19 tests and treatments are expected to work on JN.1. So far, it doesn’t appear to cause more severe disease but it does seem to have advantages over the other strains.

“While there is a rapid increase in JN.1 infections, and likely increase in cases, available limited evidence does not suggest that the associated disease severity is higher as compared to other circulating variants,” WHO said in its risk assessment of the strain.

Coronavirus vaccines are also expected to work on JN.1. “Current vaccines, including those based on ancestral strain as well as the updated monovalent XBB vaccines continue to provide protection against severe disease and death, including against JN.1,” WHO’s Maria Van Kerkhove said on social media.

ALSO READ-India Topped SE Asia in Malaria Cases and Deaths: WHO

Previous Story

Controversial Colorado Ruling Spurs GOP Action

Next Story

India Emphasizes Counter terrorism Efforts in Afghanistan

Latest from -Top News

Taipei Gets Tough on Beijing

The new move marks one of the most comprehensive efforts in recent years to strengthen Taiwan’s legal defences against Beijing’s covert attempts…reports Asian Lite News Taiwanese lawmakers from both the ruling and

Pakistan Warns Afghanistan War

Pakistan’s Defence Minister Khawaja Asif warned that Islamabad could enter an “open war” with Kabul if peace talks in Istanbul fail to ease rising Afghan border tensions…reports Asian Lite News Pakistan’s Defence

UN Signs Landmark Cybercrime Treaty

Malaysia’s foreign minister warned ASEAN is losing neutrality amid rising global power competition, ahead of the bloc’s annual summit….reports Asian Lite News Sixty-five nations have signed a landmark United Nations convention in

Malaysia Warns ASEAN Neutrality Eroding

Malaysia’s foreign minister warned ASEAN is losing neutrality amid rising global power competition, ahead of the bloc’s annual summit….reports Asian Lite News  Malaysia’s foreign minister has warned Southeast Asian counterparts that the
Go toTop

Don't Miss

Spend ‘second wave’ for reading

The year 2020 brought about a paradigm shift in everyone’s

COVID Deaths Soar to 10,000 in December Due to Holiday Spread

Although Covid-19 no longer constitutes a global health emergency, the